Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of ...

Stryker now expects sales to grow 9.8% to 10.2% in the full year, up from prior guidance of 9.5% to 10% growth. The company ...

What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Stryker (NYSE:SYK) shares dipped slightly today on third-quarter results that topped the consensus Wall Street forecast.

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

Discover Stryker's Q3 2025 earnings call insights—organic growth, margin expansion, new acquisitions, and an upbeat outlook.

Stryker has agreed to acquire Vocera Communications for $2.97 billion, kicking off medtech M&A in the new year. Vocera specializes in communication and workflow platforms as well as software for ...

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...